Liminatus Pharma, Inc. - Common Stock, $0.0001 par value per share (LIMN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
LIMN on Nasdaq
Shares outstanding
25,974,026
Price per share
$0.64
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
261,924
Total reported value
$437,442
% of total 13F portfolios
0%
Share change
+57,222
Value change
+$66,194
Number of holders
10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Liminatus Pharma, Inc. - Common Stock, $0.0001 par value per share (LIMN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Iris Acquisition Holdings LLC 26% 6,900,000 Iris Acquisition Holdings LLC 30 Apr 2025
Valetudo Therapeutics LLC 24% 6,169,406 Valetudo Therapeutics LLC 30 Apr 2025
KH Feelux Co., Ltd 15% $26,400,000 4,000,000 KH Feelux Co., Ltd 30 Apr 2025
Ewon Comfortech Co., Ltd. 5.8% $9,900,000 1,500,000 Ewon Comfortech Co., Ltd. 30 Apr 2025
Nongae Apple Association 1st 5.7% $9,702,000 1,470,000 Nongae Apple Association 1st 30 Apr 2025
Red Peony Association 1st 5.7% $9,702,000 1,470,000 Red Peony Association 1st 30 Apr 2025

As of 30 Sep 2025, 10 institutional investors reported holding 261,924 shares of Liminatus Pharma, Inc. - Common Stock, $0.0001 par value per share (LIMN). This represents 1% of the company’s total 25,974,026 outstanding shares.

Institutional Holders of Liminatus Pharma, Inc. - Common Stock, $0.0001 par value per share (LIMN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 261,924 $437,442 +$66,194 $1.67 10
2025 Q2 204,702 $2,282,195 +$2,282,196 $11.15 10